International Travel and Sexually Transmitted Disease [4]

Emerging Infectious Diseases

Volumn 9, Issue 12, 2003, Pages 1654-1656

  Etkind, Paul ^a   Ratelle, Sylvie ^a   George, Harvey ^a  

^a MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; GONORRHEA; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; LETTER; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; NONHUMAN; SEXUALLY TRANSMITTED DISEASE; TRAVEL;

EID: 0345169004     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0912.030210     Document Type: Letter

References (19)

1. Ryan ET, Wilson ME, Kain KC. Illness after international travel. N Engl J Med 2002;347:505-16.
2. Ryan ET, Kain KC. Health advice and immunizations for travelers. N Engl J Med 2000;342:1716-25.
3. Harry TC. Infectious syphilis and importance of travel history. Lancet 2002;359:447-8.
4. World Health Organization. The state of the world health, In: The world health report 1996: fighting disease, fostering development. Geneva: The Organization; 1997. p. 1-62.
5. Matteelli A, Carosi G. Sexually transmitted disease in travelers. Clin Infect Dis 2001;32:1063-7.
6. Cabada MM, Echevarria JI, Seas CR, Navarte G, Samalvides F, Freedman D, et al. Sexual behavior of international travelers visiting Peru. Sex Transm Dis 2002;29:510-3.
7. Bloor M, Thomas M, Hood K, Abdeni D, Goujon C, Hausser D, et al. Differences in sexual risk behaviour between young men and women travelling abroad from the UK. Lancet 1998;352:1664-8.
8. Gerbase AC, Rowley JT, Mertens TE. Global epidemiology of sexually transmitted diseases. Lancet 1998;351(Suppl 3): 2-4.
9. Wasserheit JN, Aral SO. The dynamic topology of sexually transmitted disease epidemics: implications for prevention strategies. J Infect Dis 1996;174(Suppl 2):S201-13.
10. Thompson MM, Najera R. Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into western countries. Clin Infect Dis 2001;32:1732-7.
11. World Health Organization/Global Program on AIDS. Global prevalence and incidence estimates of selected curable sexually transmitted diseases: Overview and estimates. Geneva: The Organization; 1995. p. 1-26.
12. Van Dyck E, Crabbe E, Neila N, Bogaerts J, Munyabikali JP, Ghys P, et al. Increasing persistence of Neisseria gonorrhoeae in west and central Africa. Consequence on therapy of gonococcal infection. Sex Transm Dis 1997;24:32-7.
13. Tapsall JW, Phillips EA, Schultz TR, Thacker C. Quinolone-resistant Neisseria gonorrhoeae isolated in Sydney, Australia, 1991 to 1995. Sex Transm Dis 1996;23:425-8.
14. Lewis DA, Bond M, Butt KD, Smith CP, Shafi MS, Murphy SM. A one-year survey of gonococcal infection seen in the genitourinary medicine department of a London district general hospital. Int J STD AIDS 1999;10:588-94.
15. WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2000. Commun Dis Intell 2001;25:274-6.
16. Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae-Hawaii and California. MMWR Morb Mortal Wkly Rep 2002;51:1041-4.
17. Kingston M, Warren C, Carlin E. Tropical warts. Lancet 2001;358:808.
18. Mulhall BP. Sexual behaviour in travellers. Lancet 1999;353:595-6.
19. Abdullah AS, Hedley AJ, Fielding R. Sexual behaviour in travellers. Lancet 1999;353:595-6.